February 8, 2017 by Megan Moyer and Chain Drug Review
front-end strategies, Hamacher Resource Group, Megan Moyer, pharmacy customers
2017, Featured Articles, Issue 02-06-2017, Issues, Leading Headlines, Opinion
The front end of your stores holds great potential, and you have strategies in place to optimize those sales. But the industry shifts and changes every year. So it might be time to review those front-end strategies to ensure you are making the most of everything available to help improve the income generated in that
February 6, 2017 by Greg Jacobson and Chain Drug Review
Affordable Care Act, Bill Cassidy, Chuck Schumer, Kellyanne Conway, Obamacare, Obamacare Replacement Act, Patient Freedom Act of 2017, President Donald Trump, Rand Paul, repeal the ACA, Susan Collins
2017, Issue 02-06-2017, Issues, News
WASHINGTON — In his first executive order after taking office, President Donald Trump ordered federal agencies to waive or delay any provisions of the Affordable Care Act they consider onerous to individuals, states or insurers. The order contained few specifics, however, and raised more questions about the fate and direction of the country’s health care
February 6, 2017 by Geoff Walden and Chain Drug Review
CVS Health, David Denton, Edith Ramirez, Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Stefano Pessina, Terrell McSweeny, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 02-06-2017, Issues, News
WASHINGTON — The acquisition of Rite Aid Corp. by Walgreens Boots Alliance (WBA) Inc. remained unconsummated after WBA’s plan to divest 865 stores failed to erase antitrust regulators’ competitive concerns. When the Friday, January 27, deadline for completing the Walgreens-Rite Aid merger deal arrived, the Federal Trade Commission still hadn’t cleared the transaction, despite the
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Aetna, Aetna-Humana merger, Affordable Care Act, Anthem-Cigna merger, Bruce Broussard, health insurers, Humana, Mark Bertolini, Medicare Advantage
2017, Issue 02-06-2017, Issues, News
WASHINGTON — A federal judge last month temporarily blocked Aetna Inc.’s proposed acquisition of Humana Inc. The move stemmed from a ruling on a lawsuit brought last year by the Justice Department to prevent the health insurers from merging on the grounds that the deal would produce higher prices for consumers and fewer services for
February 6, 2017 by Scot Meyer and Chain Drug Review
Adrenaclick, Amedra Pharmaceuticals, CVS Health, CVS Pharmacy, Douglas Boothe, epinephrine auto-injector, EpiPen, Helena Foulkes, Impax Laboratories, mylan
2017, Issue 02-06-2017, Issues, News
WOONSOCKET, R.I. — CVS Health is providing a low-cost alternative Mylan’s EpiPen epinephrine auto-injector for anaphylaxis. CVS has made Impax Laboratories’ epinephrine auto-injector available at all CVS Pharmacy drug stores at a cash price of $109.99 for a two-pack. That compares with a cash price of $649.99 for the branded EpiPen and $339.99 for the
February 6, 2017 by Scot Meyer and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HHS secretary, Orrin Hatch, Tom Price, Trump administration
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Tom Price, an orthopedic surgeon, a six-term Republican congressman from Georgia and a fierce critic of the Affordable Care Act, faced tough questions from Democrats about ethical issues and policy priorities during his confirmation hearing. But at presstime it appeared that he would be approved as Secretary of the Department of Health and
February 6, 2017 by Geoff Walden and Chain Drug Review
NACDS, National Association of Chain Drug Stores, pharmacist provider status, Pharmacy and Medically Underserved Areas Enhancement Act, provider status legislation, Steve Anderson
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Pharmacist provider status legislation was reintroduced in the House of Representatives last month with the original bipartisan cosponsorship of nearly one-quarter of the members. The Senate bill had been reintroduced eight days earlier. The National Association of Chain Drug Stores thanked lead House sponsors Brett Guthrie (R., Ky.), G.K. Butterfield (D., N.C.), Tom
February 6, 2017 by Mark Baumgartner and Chain Drug Review
FedEx, FedEx Onsite, Raj Subramaniam, Reuben Slone, Walgreens, Walgreens Boots Alliance
2017, Issue 02-06-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. and FedEx Corp. announced an agreement to provide convenient access to FedEx drop-off and pickup services in nearly 8,000 Walgreens locations by the fall of 2018. The companies said there would be a small-scale rollout this spring and that the program would be available at thousands of Walgreens
February 6, 2017 by Scot Meyer and Chain Drug Review
Bartell Drugs, Ryan Short, weekly ad circular
2017, Issue 02-06-2017, Issues, News
SEATTLE — Bartell Drugs has revamped its weekly ad circular, switching from a broadsheet to a tabloid format, and using cleaner graphics and feature-oriented headings to make it easier for consumers to read and use. “We’ve completely redesigned the piece with the customer in mind,” says Bartells senior marketing manager Ryan Short. “The circular has
February 6, 2017 by Scot Meyer and Chain Drug Review
Dedra Castle, John Standley, Ken Black, Rite Aid
2017, Issue 02-06-2017, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. has promoted Ken Black to senior vice president and chief human resources officer. He succeeds Dedra Castle, who is leaving the company for personal health reasons. “On behalf of the entire Rite Aid team, I thank Dedra for her many significant contributions to our company,” Rite Aid chairman
February 6, 2017 by Brian Bossetta
Accenture, Blue Cross Blue Shield Association, Harris Poll, in-store clinics, Maureen Sullivan, Nielsen, retail clinic growth, retail health clinics
2017, Issue 02-06-2017, Issues, Leading Headlines, News
NEW YORK — Findings from a pair of studies reveal positive trends for retail health clinics. A recent Harris Poll for Nielsen on patients visiting in-store clinics might hold vital information for retailers focusing on health and wellness, and a study conducted by the Blue Cross Blue Shield Association (BCBSA) found retail health clinic visits
February 6, 2017 by Scot Meyer and Chain Drug Review
Brian Cornell, Jeff Jones, Rick Gomez, Target Corp.
2017, Issue 02-06-2017, Issues, News
MINNEAPOLIS — Target Corp. has named Rick Gomez to the position of executive vice president and chief marketing officer. Gomez succeeds Jeff Jones, who left the company in September to join Uber Technologies Inc. In his new role, Gomez will be responsible for furthering Target’s brand positioning and leading the integration of all the retailer’s
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Amy Klobuchar, Bernie Sanders, importation of prescription drugs, NACDS, National Association of Chain Drug Stores, prescription drug safety, prescription drugs from Canada
2017, Issue 02-06-2017, Issues, News
ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) sent a letter to all 100 U.S. senators last month ahead of a vote on an amendment that would allow Americans to purchase prescription drugs from Canada. In its letter, NACDS said that importation undermines the prescription drug safety net. “NACDS shares the goal
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Andy Becker, Drew Massey, Fruth Pharmacy, John Galvan
2017, Issue 02-06-2017, Issues, News
POINT PLEASANT, W.Va. — Fruth Pharmacy recently announced three personnel moves, including the promotion of John Galvan to vice president of operations. In addition, the West Virginia-based drug chain promoted Drew Massey to director of pharmacy operations and hired Andy Becker as director of pharmacy administration. Galvan, who had been director of operations, was promoted